These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24388295)

  • 1. Type 1 diabetes--progress and prospects.
    The Lancet
    Lancet; 2014 Jan; 383(9911):2. PubMed ID: 24388295
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of intensive blood-glucose control.
    Kiln MR
    Lancet; 1993 Jul; 342(8862):59. PubMed ID: 8100334
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G
    Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glycemic control and late complications of insulin-dependent diabetes: is it necessary to change our treatment strategies?].
    Slama G; Selam JL
    Journ Annu Diabetol Hotel Dieu; 1994; ():111-6. PubMed ID: 8051811
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of type-I diabetes mellitus in pregnancy.
    Maas R
    Eur J Obstet Gynecol Reprod Biol; 1991 Dec; 42 Suppl():S56-60. PubMed ID: 1809611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control and complications of diabetes mellitus.
    Hirsch IB
    West J Med; 1995 May; 162(5):430-8. PubMed ID: 7785257
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose products.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):76-7. PubMed ID: 25868301
    [No Abstract]   [Full Text] [Related]  

  • 8. Difficulties describing feelings to others still predicts glycaemic control up to 24 months later in children with type 1 diabetes.
    Housiaux M; Luminet O; Dorchy H
    Diabetes Metab; 2016 Jun; 42(3):207-10. PubMed ID: 26782009
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycemic control and type 1 diabetes: the differential impact of model of care and income.
    Hatherly K; Smith L; Overland J; Johnston C; Brown-Singh L; Waller D; Taylor S
    Pediatr Diabetes; 2011 Mar; 12(2):115-9. PubMed ID: 20522168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DCCT findings and standards of care for diabetes.
    Peterson KA; Smith CK
    Am Fam Physician; 1995 Sep; 52(4):1092-8. PubMed ID: 7668198
    [No Abstract]   [Full Text] [Related]  

  • 11. A Desktop Guide to Type 1 (Insulin-dependent) Diabetes Mellitus: European Diabetes Policy Group 1998, International Diabetes Federation, European Region.
    Exp Clin Endocrinol Diabetes; 1998; 106(4):240-69. PubMed ID: 9792457
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexplained improvement in diabetes control: a wolf in sheep's clothing.
    Snow KJ
    Compr Ther; 1995 Oct; 21(10):590-3. PubMed ID: 8565428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes therapy in the elderly for better prognosis and well-being. Which strategies are suitable?].
    Beischer W
    MMW Fortschr Med; 1999 Sep; 141(36):36-40. PubMed ID: 10904596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coeliac disease and its relation to glycaemic control in adults with type 1 diabetes mellitus.
    Depczynski B
    Diabetes Res Clin Pract; 2008 Jan; 79(1):e10. PubMed ID: 17681392
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Diabetes Reserach in Children Network (DirecNet) Study Group
    Diabetes Care; 2007 Jan; 30(1):185; author reply 187-9. PubMed ID: 17192364
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Service FJ; O'Brien PC
    Diabetes Care; 2007 Jan; 30(1):186; author reply 187-8. PubMed ID: 17192366
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis: toward algorithms in diabetes self-management.
    Albisser AM
    Diabetes Technol Ther; 2003; 5(3):371-3. PubMed ID: 12828819
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.